{Reference Type}: Case Reports
{Title}: Psoriasiform graft-versus-host disease responded to secukinumab: A case report.
{Author}: Gu Y;Sun J;Zhang J;
{Journal}: Australas J Dermatol
{Volume}: 64
{Issue}: 4
{Year}: 2023 Nov 31
{Factor}: 2.481
{DOI}: 10.1111/ajd.14144
{Abstract}: We describe a 9-year-old boy who developed generalised erythematous lesions 12 months after haematopoietic stem cell transplant (HSCT). Histopathology showed both features of psoriasis and graft-versus-host disease (GVHD). The lesions responded well to secukinumab, suggesting that IL-17A monoclonal antibody might be a treatment option for GVHD.